Prostate gland growth

pathway activity — cross-omics
GO:0060736Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Prostate gland growth pathway is significantly associated with the protein abundance of multiple proteins, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are CD163, FCER1G, and ISG20, each associated with the pathway in up to 8 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Prostate gland growth activity versus CD163 in GBM (Pearson r = -0.17).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMCD163 →-1.048-0.159<.001<.00138
CCRCCFCER1G →-0.576-0.065.001.00238
BRCAISG20 →-0.578-0.095<.001<.00138
BRCALCP2 →-0.461-0.115<.001<.00138
HNSCWIPF1 →-0.343-0.090.003.00138
LSCCFMNL1 →-0.437-0.077<.001<.00138
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0060736 vs CD163 — GBM

Per-sample scatter of Prostate gland growth activity vs CD163 in GBM.

Explore this scatter interactively →

Exploration